BellMark Partners, LLC advised Stratford Pharmaceuticals, LLC (the “Company” or “Stratford”) in its recapitalization with Eli Global, LLC, a Durham, North Carolina based family office that owns a conglomeration of independent investments across various healthcare and animal healthcare sectors.

Business Description
Headquartered in Oldsmar, Florida, Stratford is a leading provider of branded, co-branded, and private label topical dermatology products and dosage form animal health and wellness products to veterinary clinics throughout the U.S. and Europe. Leveraging its innovative product delivery forms, unique co-branding product program, and a multi-channel distribution strategy, the Company has penetrated the growing animal health market, distributing products to more than 10,000 veterinary clinics. The Company’s proprietary co-branding program is the largest of its kind in the U.S., offering an attractive value proposition for veterinary clinic customers looking to increase profitability and repeat products sales.

Transaction Description
BellMark Partners, LLC acted as the Company’s exclusive financial advisor in connection with the completion of this transaction. BellMark Partners, LLC was selected by the Company due to its industry experience and senior level attention to transaction execution.

For further information please contact Brian Nugent, President and CEO, Stratford Pharmaceuticals at brian@stratfordrx.com or Dave Gesmondi, Managing Director, BellMark Partners LLC, at dave@bellmarkpartners.com.